ACLX - Arcellx, Inc.
114.3
0.250 0.219%
Share volume: 1,294,952
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.44%
PREVIOUS CLOSE
CHG
CHG%
$114.05
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-07-2024 | 02-27-2025 | 05-08-2025 | 11-05-2025 | 02-26-2026 | |
| Assets | ||||||||
| Total Assets | 779.695 M | 734.306 M | 764.909 M | 711.327 M | 648.082 M | 655.918 M | 603.990 M | |
| Current Assets | 588.733 M | 530.203 M | 587.301 M | 599.310 M | 554.154 M | 472.081 M | 462.183 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 419.345 M | 416.663 M | 412.408 M | 481.696 M | 462.404 M | 382.378 M | 370.072 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 154.574 M | 100.025 M | 161.846 M | 105.679 M | 80.861 M | 79.005 M | 80.262 M | |
| Total Non-current Assets | 117.102 M | 130.128 M | 102.428 M | 38.277 M | 21.942 M | 114.591 M | 69.716 M | |
| Property Plant Equipment | 44.930 M | 46.276 M | 47.497 M | 46.456 M | 45.568 M | 43.076 M | 42.639 M | |
| Other Assets | 146.032 M | 157.827 M | 128.780 M | 65.561 M | 48.360 M | 140.761 M | 99.168 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 779.695 M | 734.306 M | 764.909 M | 711.327 M | 648.082 M | 655.918 M | 603.990 M | |
| Total liabilities | 283.122 M | 247.142 M | 281.891 M | 256.535 M | 231.176 M | 215.141 M | 201.639 M | |
| Total current liabilities | 107.901 M | 88.290 M | 137.017 M | 125.405 M | 112.461 M | 118.392 M | 104.202 M | |
| Accounts Payable | 3.099 M | 4.868 M | 5.989 M | 2.095 M | 4.369 M | 4.204 M | 5.576 M | |
| Other liabilities | 63.153 M | 62.771 M | 62.262 M | 131.130 M | 49.268 M | 44.323 M | 97.437 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 63.153 M | 62.771 M | 62.262 M | 131.130 M | 49.268 M | 44.323 M | 97.437 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 496.573 M | 487.164 M | 483.018 M | 454.792 M | 416.906 M | 440.777 M | 402.351 M | |
| Common stock | 893.763 M | 911.836 M | 930.866 M | 950.772 M | 975.355 M | 1.108 B | 1.127 B | |
| Retained earnings | -396.678 M | -423.880 M | -449.747 M | -496.828 M | -559.098 M | -667.650 M | -725.762 M |